Healthcare ❯ Medical Research

Gene Therapy

Huntington's Disease Clinical Trials Adeno-Associated Virus (AAV) Neurodegenerative Treatments Hearing Restoration Rare Diseases FDA Approval Process Genetic Treatments mRNA Technology

Plaintiff Firms Step Up uniQure Solicitation After FDA Rebuke, With April 13 Lead-Plaintiff Deadline

Investor solicitations intensify following an FDA official’s public dispute of uniQure’s trial design.

CAR-Astrocyte Gene Therapy Stops Plaques, Halves Amyloid in Alzheimer’s Mice

FDA Demands Placebo-Controlled Trial for UniQure’s Huntington’s Gene Therapy

Investor Law Firms Rally uniQure Case as April 13 Lead-Plaintiff Deadline Nears

NEJM Study Finds 95% Long-Term Success for ADA-SCID Gene Therapy